Location: Kai Tak, Hong Kong
CIK: 0001782539 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $312M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | NEW FRONTIER HEALTH CORP | 8,350,000 | $93.77M | 30.0% | $11.17 | — | ORD SHS | G6461G106 |
| ILMN | ILLUMINA INC | 129,647 | $52.59M | 16.8% | $459.88 | 0.0% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 768,708 | $29.46M | 9.4% | $30.00 | +7.3% | COM | 413197104 |
| — | KARUNA THERAPEUTICS INC | 234,811 | $28.72M | 9.2% | $113.99 | — | COM | 48576A100 |
| — | SOMALOGIC INC | 1,696,558 | $21.02M | 6.7% | $12.39 | — | CLASS A COM | 83444K105 |
| — | EARGO INC | 2,886,724 | $19.43M | 6.2% | $39.91 | — | COM | 270087109 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $14.76M | 4.7% | $15.46 | — | COM | 097702104 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $8.796M | 2.8% | $17.30 | 0.0% | COM CL A | 753018100 |
| VIR | VIR BIOTECHNOLOGY INC | 160,211 | $6.972M | 2.2% | $44.22 | -2.1% | COM | 92764N102 |
| GRTX | GALERA THERAPEUTICS INC | 613,223 | $4.967M | 1.6% | $8.13 | +5.5% | COM | 36338D108 |
| BEAM | BEAM THERAPEUTICS INC | 54,903 | $4.777M | 1.5% | $82.04 | +22.5% | COM | 07373V105 |
| — | NEW FRONTIER HEALTH CORP | 1,580,000 | $4.456M | 1.4% | $2.32 | — | *W EXP 11/30/202 | G6461G114 |
| — | INVITAE CORP | 144,667 | $4.113M | 1.3% | $33.73 | — | COM | 46185L103 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $3.098M | 1.0% | $60.98 | +9.3% | COM | 00166B105 |
| XENE | XENON PHARMACEUTICALS INC | 197,880 | $3.024M | 1.0% | $18.43 | -5.7% | COM | 98420N105 |
| — | DBV TECHNOLOGIES S A | 370,950 | $1.818M | 0.6% | $5.33 | — | SPONSORED ADR | 23306J101 |
| EXAS | EXACT SCIENCES CORP | 17,464 | $1.667M | 0.5% | $119.35 | -11.5% | COM | 30063P105 |
| — | OTONOMY INC | 851,000 | $1.634M | 0.5% | $2.23 | — | COM | 68906L105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 78,720 | $1.374M | 0.4% | $26.16 | -22.5% | COM | 483497103 |
| EXEL | EXELIXIS INC | 64,200 | $1.357M | 0.4% | $23.32 | -20.4% | COM | 30161Q104 |
| — | SIERRA ONCOLOGY INC | 52,979 | $1.161M | 0.4% | $19.47 | — | COM NEW | 82640U404 |
| — | RUBIUS THERAPEUTICS INC | 56,768 | $1.015M | 0.3% | $24.42 | — | COM | 78116T103 |
| — | REATA PHARMACEUTICALS INC | 8,265 | $832K | 0.3% | $141.56 | — | CL A | 75615P103 |
| — | SATSUMA PHARMACEUTICALS INC | 142,900 | $666K | 0.2% | $4.66 | — | COM | 80405P107 |
| — | FLUENT INC | 194,800 | $442K | 0.1% | $2.93 | — | COM | 34380C102 |
| — | SYNLOGIC INC | 68,634 | $209K | 0.1% | $3.89 | — | COM | 87166L100 |
| DYN | DYNE THERAPEUTICS INC | 11,629 | $189K | 0.1% | $17.73 | 0.0% | COM | 26818M108 |
| — | AKERO THERAPEUTICS INC | 3,470 | $78,000 | 0.0% | $24.78 | — | COM | 00973Y108 |